Cargando…

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma

Sodium taurocholate cotransporting polypeptide (NTCP), encoded by gene SLC10A1, is a receptor for hepatitis B virus (HBV). The aim of the current study was to investigate the role of NTCP polymorphisms in HBV susceptibility, cirrhosis and hepatocarcinogenesis. A total 1221 cases [including 866 chron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng, Mo, Ruidong, Lai, Rongtao, Xu, Yumin, Lu, Jie, Zhao, Gangde, Liu, Yuhan, Cao, Zhujun, Wang, Xiaolin, Li, Ziqiang, Lin, Lanyi, Zhou, Huijuan, Cai, Wei, Wang, Hui, Bao, Shisan, Xiang, Xiaogang, Xie, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739647/ https://www.ncbi.nlm.nih.gov/pubmed/29285260 http://dx.doi.org/10.18632/oncotarget.22211

Ejemplares similares

Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population
por: Shang, Dabao, et al.
Publicado: (2022)

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma
por: Ding, Yezhou, et al.
Publicado: (2020)

Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening
por: Wang, Hui, et al.
Publicado: (2015)

Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients
por: Chen, Liwen, et al.
Publicado: (2018)

Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury
por: Mo, Ruidong, et al.
Publicado: (2018)

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China
por: Ding, Yezhou, et al.
Publicado: (2023)

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
por: Lou, Shike, et al.
Publicado: (2023)

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
por: Yan, Ran, et al.
Publicado: (2015)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
por: Yan, Huan, et al.
Publicado: (2023)

SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease
por: Liu, Yuhan, et al.
Publicado: (2016)

Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure
por: Cao, Zhujun, et al.
Publicado: (2015)

Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy
por: Wang, Yun, et al.
Publicado: (2016)

Innovative HBV Animal Models Based on the Entry Receptor NTCP
por: Wettengel, Jochen M., et al.
Publicado: (2020)

Structural insights into the HBV receptor and bile acid transporter NTCP
por: Park, Jae-Hyun, et al.
Publicado: (2022)

Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response
por: Xu, Yumin, et al.
Publicado: (2019)

Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells
por: Li, Xinlei, et al.
Publicado: (2021)

A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population
por: Yang, Jingmin, et al.
Publicado: (2016)

Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
por: Li, Yan, et al.
Publicado: (2022)

Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome
por: Chen, Liwen, et al.
Publicado: (2020)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells
por: Zhou, Ming, et al.
Publicado: (2017)

Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019)

Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
por: Yan, Lei, et al.
Publicado: (2018)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma
por: Liu, Kehui, et al.
Publicado: (2022)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
por: Huang, Yan, et al.
Publicado: (2022)

NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings
por: Mao, Fengfeng, et al.
Publicado: (2020)

The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment
por: Wu, Lina, et al.
Publicado: (2021)

Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients
por: Chen, Lu, et al.
Publicado: (2020)

Erratum to: Peginterferon and Entecavir Combination Therapy Improves Outcome of Non–Early Response Hepatitis B e Antigen–Positive Patients
por: Chen, Lu, et al.
Publicado: (2021)

Multitasking Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Unlocking the secrets to human NTCP structure
por: Qi, Xiangbing, et al.
Publicado: (2022)

NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance
por: Zhang, Meng-yu, et al.
Publicado: (2022)

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
por: Gad, Sameh A., et al.
Publicado: (2022)

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection
por: Zahoor, Muhammad Atif, et al.
Publicado: (2022)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Mechanistic insights into the inhibition of NTCP by myrcludex B
por: Donkers, Joanne M., et al.
Publicado: (2019)

Insufficient evidence for NTCP activity in stellate cells
por: Kunst, Roni F, et al.
Publicado: (2022)

Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl(4)-Induced Acute Liver Injury in Mice via Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22
por: Zhang, Jinming, et al.
Publicado: (2022)

Amelioration of Liver Injury by Continuously Targeted Intervention against TNFRp55 in Rats with Acute-on-Chronic Liver Failure
por: Xu, Yumin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_smha7i77oi1s2opjbv0tcpkdja